News of cancer vaccines proliferate in the media, yet only one such vaccine has been approved - against metastatic prostate cancer - and is no longer in use. However, only one as such has been approved - against metastatic prostate cancer - and it is no longer in use. Are the attention and hopes justified? What do they consist of and how are they similar to traditional ones? Are they preventive or therapeutic? Can they be universal or will they be extremely personalised? How much will they cost? This is what we know today.

In a briefing organised by the Science Media Centre Spain, Amparo Larrauri and Francisco Pozo, researchers at the Health Institute Carlos III, explained how three respiratory viruses are coexisting this autumn: influenza virus, respiratory syncytial virus (responsible for most bronchiolitis) and SARS-CoV-2.

At current CO₂ emission levels, there is a 50 % chance of exceeding 1.5°C warming in nine years. This is one of the conclusions of the Global Carbon Budget 2022 report presented by its coordinator, researcher Pep Canadell, at a briefing organised by SMC Spain.